We’ve talked about neuroinflammation and its causes and how the effects of neuroinflammation impact our brain and, therefore, our body. Accordingly, it is only fair to talk about neuro-diagnostics, applying neuro-diagnostics, and what neuro-diagnostic test to run.
About 5-10% of the global population is affected by an autoimmune disorder. Eventually, every autoimmune disorder will target the peripheral or central nervous system in different ways. Today, more than ever, we can use technology to facilitate the detection of neurological diseases, the risk of developing an autoimmune response due to a previous injury, viral disease, or infection. Finally, this finding will lead us to provide the patient with the best protocol treatment that rebuilds the intestinal barrier also prevent an autoimmune disorder.
It is important to bring back the importance of peripheral inflammation and the fact that it can lead to immunity when there is an exaggerated inflammation reaction. Hence, if the immunity reaction cannot be modulated, it can lead to autoimmunity, making us prone to neuroinflammation. Once neuroinflammation starts, our glial cells get primed and activated; hence the secretion of proinflammatory cytokines, secondary injuries, or inflammation can exacerbate a deranged effect.
This is when neuro-diagnostics need to be performed, and here we introduce you to Neuro Zoomer Plus, by Vibrant America. This amazing, complete, and standardized test is what we use when patients come in with these symptoms:
Signs and Symptoms Associated with Neurological Autoimmunity
History of concussion
Neural ZoomerTM Plus is designed to assess 48 neurological antigens that are related to numerous neurological diseases. Therefore, with specific recognition of each antibody, we can treat diseases directly from the root cause and provide a solution.
Vibrant Neural ZoomerTM Plus is a powerful, advanced, complete, and reproducible tool, and its main purpose is to detect risks for the development of serious neurological conditions. Early detection will also lead to a better treatment protocol and an improved quality of life, and preventing neurological degeneration.
Autoimmune markers included in Vibrant Neural Zoomer Plus:
The Neural Zoomer Plus
The Neural Zoomer plus determines if your patient results are positive for a specific antibody quantitatively. The positive cutoff is considered 97.5 percentile, 92.5-97.5 is considered borderline, and less than 92.5 is negative. The results can be accompanied by a Neuro Zoomer Lifestyle guide that provides an in-depth explanation of what changes need to be done and why. Learn more about Neural Zoomer Plus in this video.
In conclusion, neuroinflammation is associated with peripheral inflammation caused by viral disease and injury. Among many other factors that can promote neuroinflammation, autoimmunity plays a major role in impacting a patient’s health. Providing a complete diagnostic tool such as Neural Zoomer Pus that measures the most studied antibodies is essential to provide the best treatment protocol.
Neural Zoomer Plus. Vibrant America. 2020
The information herein on " Neuro-Diagnostics " is not intended to replace a one-on-one relationship with a qualified health care professional, licensed physician, and is not medical advice. We encourage you to make your own health care decisions based on your research and partnership with a qualified health care professional. Our information scope is limited to chiropractic, musculoskeletal, physical medicines, wellness, sensitive health issues, functional medicine articles, topics, and discussions. We provide and present clinical collaboration with specialists from a wide array of disciplines. Each specialist is governed by their professional scope of practice and their jurisdiction of licensure. We use functional health & wellness protocols to treat and support care for the injuries or disorders of the musculoskeletal system. Our videos, posts, topics, subjects, and insights cover clinical matters, issues, and topics that relate to and support, directly or indirectly, our clinical scope of practice.* Our office has made a reasonable attempt to provide supportive citations and has identified the relevant research study or studies supporting our posts. We provide copies of supporting research studies available to regulatory boards and the public upon request.
We understand that we cover matters that require an additional explanation of how it may assist in a particular care plan or treatment protocol; therefore, to further discuss the subject matter above, please feel free to ask Dr. Alex Jimenez or contact us at 915-850-0900.